rs45606837
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001557.4(CXCR2):c.936C>T(p.Leu312Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 1,614,158 control chromosomes in the GnomAD database, including 217 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 16 hom., cov: 31)
Exomes 𝑓: 0.013 ( 201 hom. )
Consequence
CXCR2
NM_001557.4 synonymous
NM_001557.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.595
Publications
4 publications found
Genes affected
CXCR2 (HGNC:6027): (C-X-C motif chemokine receptor 2) The protein encoded by this gene is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth. This receptor mediates neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal microvascular endothelial cells are found to be mediated by this receptor. Knockout studies in mice suggested that this receptor controls the positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. This gene, IL8RA, a gene encoding another high affinity IL8 receptor, as well as IL8RBP, a pseudogene of IL8RB, form a gene cluster in a region mapped to chromosome 2q33-q36. Alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]
CXCR2 Gene-Disease associations (from GenCC):
- WHIM syndrome 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal recessive severe congenital neutropenia due to CXCR2 deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 2-218135737-C-T is Benign according to our data. Variant chr2-218135737-C-T is described in ClinVar as Benign. ClinVar VariationId is 1164697.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.595 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0102 (1558/152270) while in subpopulation SAS AF = 0.0384 (185/4816). AF 95% confidence interval is 0.0339. There are 16 homozygotes in GnomAd4. There are 852 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CXCR2 | NM_001557.4 | c.936C>T | p.Leu312Leu | synonymous_variant | Exon 3 of 3 | ENST00000318507.7 | NP_001548.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CXCR2 | ENST00000318507.7 | c.936C>T | p.Leu312Leu | synonymous_variant | Exon 3 of 3 | 1 | NM_001557.4 | ENSP00000319635.2 | ||
| ENSG00000305582 | ENST00000811769.1 | n.152+4153G>A | intron_variant | Intron 2 of 2 | ||||||
| ENSG00000305582 | ENST00000811770.1 | n.208+4153G>A | intron_variant | Intron 3 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0103 AC: 1560AN: 152152Hom.: 17 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1560
AN:
152152
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0137 AC: 3434AN: 251476 AF XY: 0.0156 show subpopulations
GnomAD2 exomes
AF:
AC:
3434
AN:
251476
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0126 AC: 18440AN: 1461888Hom.: 201 Cov.: 34 AF XY: 0.0135 AC XY: 9847AN XY: 727246 show subpopulations
GnomAD4 exome
AF:
AC:
18440
AN:
1461888
Hom.:
Cov.:
34
AF XY:
AC XY:
9847
AN XY:
727246
show subpopulations
African (AFR)
AF:
AC:
78
AN:
33480
American (AMR)
AF:
AC:
179
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
396
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39698
South Asian (SAS)
AF:
AC:
2903
AN:
86258
European-Finnish (FIN)
AF:
AC:
1005
AN:
53420
Middle Eastern (MID)
AF:
AC:
137
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
12934
AN:
1112008
Other (OTH)
AF:
AC:
805
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1230
2460
3691
4921
6151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0102 AC: 1558AN: 152270Hom.: 16 Cov.: 31 AF XY: 0.0114 AC XY: 852AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
1558
AN:
152270
Hom.:
Cov.:
31
AF XY:
AC XY:
852
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
79
AN:
41538
American (AMR)
AF:
AC:
107
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
53
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5184
South Asian (SAS)
AF:
AC:
185
AN:
4816
European-Finnish (FIN)
AF:
AC:
258
AN:
10624
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
845
AN:
68014
Other (OTH)
AF:
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
76
152
228
304
380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.